WOBURN, Mass. and DAEJEON, Korea--(BUSINESS WIRE)--Panagene and AdvanDx, Inc. have entered into an exclusive supply agreement under which Panagene will manufacture PNA probes for incorporation into AdvanDx’s PNA FISH in vitro diagnostic products. AdvanDx, Inc.’s molecular-based tests provide rapid species identification of bacteria and yeast from positive blood cultures in less than three hours. The rapid results support clinicians in making faster and more relevant therapy decisions that can improve antibiotic management, reduce hospital mortality, and reduce costs associated with bloodstream infections.1,2,3,4 A series of new products incorporating PNA probes manufactured by Panagene was introduced at the American Society of Microbiology (ASM) 2007 meeting in Toronto.
